We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01259869
Recruitment Status : Completed
First Posted : December 14, 2010
Last Update Posted : April 13, 2015
Sponsor:
Collaborator:
Cascadian Therapeutics Inc.
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )